Outcomes of the IMMray PanCan-d Test in High-Risk Individuals Undergoing Pancreatic Surveillance: Pragmatic Data and Lessons Learned.

Bryson W KatonaChristine WorthingtonDaniel ClayHannah CincottaNuzhat A AhmadGregory G GinsbergMichael L KochmanRandall E Brand

Published in: JCO precision oncology (2023)

In clinical practice, IMMray PanCan-d has a robust NPV; however, PPV is dramatically influenced by whether borderline results are characterized as a positive or negative result.

Keyphrases

clinical practice
public health
electronic health record
study protocol
big data
randomized controlled trial
clinical trial
data analysis
insulin resistance